Our neuroscience team is motivated to continue the delivery of therapies for nervous system disorders. The team at Carimer also has a deep understanding of the complex issues involved in conducting psychiatric clinical trials, such as patient recruitment and retention, placebo response, and regulatory requirements. We operate with a keen interest in navigating the complex regulatory guidelines that are involved in CNS and psychiatric trials while ensuring the success of the investigational product.
 
Our investigators have extensive experience in psychiatry and neurology, opening global access to targeted patient populations. Our investigators work with clients to promote improved care while understanding study specifics.